DEERFIELD, Ill.--(BUSINESS WIRE)--May 7, 2018--
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today it will
hold a Sell-Side Analyst Event on Tuesday, 22 May in New York City. The
event will be hosted by Walgreens Boots Alliance Executive Vice Chairman
and CEO Stefano Pessina, Co-Chief Operating Officer Alex Gourlay and
Global Chief Financial Officer George Fairweather; and by Walgreens
President of Operations Richard Ashworth.
In-person attendance is by invitation only; however, the event will be
webcast live. The listen-only audio webcast and copies of any related
material will be available on the Walgreens Boots Alliance investor
relations website at http://investor.walgreensbootsalliance.com/events.cfm
beginning at 10 a.m. Eastern time. The event is expected to conclude at
1 p.m. Eastern time.
Shortly after the event, a replay of the webcast will be posted on the
investor relations website.
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led,
health and wellbeing enterprise. The company's heritage of trusted
health care services through community pharmacy care and pharmaceutical
wholesaling dates back more than 100 years.
Walgreens Boots Alliance is the largest retail pharmacy, health and
daily living destination across the U.S. and Europe. Walgreens Boots
Alliance and the companies in which it has equity method investments
together have a presence in more than 25* countries and employ more than
385,000* people. The company is a global leader in pharmacy-led, health
and wellbeing retail and, together with the companies in which it has
equity method investments, has more than 13,200* stores in 11* countries
as well as one of the largest global pharmaceutical wholesale and
distribution networks, with more than 390* distribution centers
delivering to more than 230,000** pharmacies, doctors, health centers
and hospitals each year in more than 20* countries. In addition,
Walgreens Boots Alliance is one of the world’s largest purchasers of
prescription drugs and many other health and wellbeing products.
The company’s portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands, such as No7, Soap
& Glory, Liz Earle, Sleek MakeUP and Botanics.
More company information is available at www.walgreensbootsalliance.com.
* As of 31 August 2017, using publicly available information for
AmerisourceBergen.
** For 12 months ending 31 August 2017, using publicly available
information for AmerisourceBergen
(WBA-GEN)
Cautionary Note Regarding Forward-Looking Statements: All statements
in this release and related webcast that are not historical are
forward-looking statements made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements are not guarantees of future performance and
involve risks, assumptions and uncertainties, including those described
in Item 1A (Risk Factors) of our Form 10-K for the fiscal year ending 31
August 2017 and our Form 10-Q for the fiscal quarter ending 30 November
2017, each of which is incorporated herein by reference, and in other
documents that Walgreens Boots Alliance files or furnishes with the
Securities and Exchange Commission. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially. These forward-looking
statements speak only as of the date they are made. Except to the extent
required by law, Walgreens Boots Alliance does not undertake, and
expressly disclaims, any duty or obligation to update publicly any
forward-looking statement after the date of this release, whether as a
result of new information, future events, changes in assumptions or
otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180507005449/en/
Source: Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
Media Relations
USA /
Michael Polzin, +1 847 315 2935
International / Laura Vergani, +44
(0)207 980 8585
or
Investor Relations
Gerald
Gradwell and Ashish Kohli, +1 847 315 2922